Global Cell & Gene Therapy Manufacturing Market Report 2026-2036
Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Global Cell & Gene Therapy Manufacturing Market Report 2026-2036" report has been added to ResearchAndMarkets.com's offering.
This report provides a comprehensive analysis of the global cell and gene therapy manufacturing market, including market size, growth drivers, competitive positioning, and revenue forecasts across therapy type, source of cells, scale of operation, type of manufacturer, and workflow segments.
The global cell and gene therapy manufacturing market is valued at US$13.7bn in 2026 and is forecast to reach US$63.0bn by 2036, at a CAGR of 16.5% over the forecast period.
This growth is driven by the expanding global clinical pipeline of cell and gene therapies, increasing commercial approvals, accelerating investment in dedicated manufacturing infrastructure, and advancing bioprocessing and automation technologies that are improving the scalability and commercial viability of advanced therapy production.
Technological Innovation Driving Market Expansion
Advances in bioprocessing technologies and manufacturing automation are significantly improving the efficiency, consistency, and scalability of cell and gene therapy production. The increasing adoption of automated manufacturing systems, closed-process platforms, and real-time digital monitoring is reducing manual intervention, lowering contamination risk, and enhancing batch-to-batch consistency. These capabilities are particularly important for autologous cell therapies, where maintaining chain-of-identity and chain-of-custody throughout manufacturing is essential to product quality and patient safety.
In May 2026, Thermo Fisher Scientific introduced an integrated platform designed to enable more scalable and standardised cell therapy manufacturing, reflecting the industry's broader transition toward automated and digitally enabled production environments. The growing implementation of Process Analytical Technology (PAT) is further strengthening manufacturing performance by enabling continuous process monitoring, tighter process control, and earlier identification of production deviations.
Innovations in both upstream and downstream bioprocessing are improving production throughput, increasing facility utilisation, and supporting more efficient technology transfer across manufacturing sites. As these technologies mature, manufacturers are expected to achieve higher productivity, improved product consistency, and lower production costs across the value chain.
Trade, Policy & Supply Chain Dynamics
Commercial Impact
Company Intelligence
The cell and gene therapy manufacturing market is characterised by a mix of global CDMO leaders, specialist advanced therapy manufacturers, and large pharmaceutical companies competing across manufacturing capability, regulatory expertise, and technology platform breadth.
Leading companies including Lonza, Thermo Fisher Scientific, Catalent, Charles River Laboratories, and Fujifilm Diosynth Biotechnologies are strengthening their positions through capacity expansion, technology investment, and strategic partnerships across viral vector, cell therapy, and fill-finish manufacturing.
Competition is increasingly defined by:
This report analyses how competitive positioning is evolving across 16 leading companies, identifying where value is being created and how strategies are expected to shift over the forecast period.
Key Questions Answered
Report Scope and Data Coverage
Includes both quantitative forecasting and qualitative strategic analysis, covering technology, competition, policy, and supply chain dynamics.
Segmentation Framework
By Therapy Type
By Source of Cells
By Scale of Operation
By Type of Manufacturer
By Workflow
Geographic Coverage
North America
Europe
Asia Pacific
Latin America
MEA
Each profile includes:
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/qhw6j0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.